Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
Adenosine pathway inhibition is a promising investigational strategy in breast cancer, especially for immunologically “cold” or aggressive disease such as triple-negative breast cancer, but it is not an established standard therapy as of now. The main targets are CD73, CD39, and adenosine receptors - particularly A2A and sometimes A2B - because adenosine-…